Contact us

As countries to further intensify the support of biotechnology industry, with biological products as the main body of the refrigerated drugs cold chain logistics industry also obtained fast development. The vast majority of biological products need low temperature preservation and transportation, cold chain quality higher and stricter standards, standard operation, cold chain has become a key link in the process of biological products quality guarantee. Refrigerated drugs global annual growth rate of more than 15%, far higher than other drugs the growth rate of around 7%.

In China, refrigerated drug sales amount of Chinese medicine circulation enterprises commonly 7% ~ 8% of total sales, drug upward trend is obvious. According to official statistics, in 2010-2014, our country medicine market scale growth from 675 billion yuan to 1.2413 trillion yuan, an average annual compound growth rate of 16.5%. Since 2013 our country medicine market growth is slowing, at 14.8% in 2013, about 12.9% in 2014. 1, March 2015, China's pharmaceutical enterprises above designated size main business income is 581.937 billion yuan, up 9.6% from a year earlier, the growth rate fell 4.2% year-on-year. However, due to an aging population, disease burden ability enhancement, health awareness, and many other factors, our country medicine market will continue to maintain rapid growth, in 2019 our country medicine market scale is expected to exceed 2.2 trillion yuan. Under this background, the medicine logistics market will drive medical refrigerator broad space for development.